40 related articles for article (PubMed ID: 10830747)
21. Involvement of Rel/NF-kappa B transcription factors in senescence.
Gosselin K; Abbadie C
Exp Gerontol; 2003; 38(11-12):1271-83. PubMed ID: 14698807
[TBL] [Abstract][Full Text] [Related]
22. BCL-2: physiology and role in neoplasia.
Bagg A; Cossman J
Cancer Treat Res; 1992; 63():141-66. PubMed ID: 1363355
[No Abstract] [Full Text] [Related]
23. Regulation of B-cell function by NF-kappaB c-Rel in health and disease.
Basavarajappa SC; Ramakrishnan P
Cell Mol Life Sci; 2020 Sep; 77(17):3325-3340. PubMed ID: 32130429
[TBL] [Abstract][Full Text] [Related]
24. The molecular genetics of post-transplantation lymphoproliferative disorders.
Knowles DM
Springer Semin Immunopathol; 1998; 20(3-4):357-73. PubMed ID: 9870251
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of lymphoid malignancies.
Staudt LM
Annu Rev Med; 2002; 53():303-18. PubMed ID: 11818476
[TBL] [Abstract][Full Text] [Related]
26. c-Rel and its many roles in cancer: an old story with new twists.
Hunter JE; Leslie J; Perkins ND
Br J Cancer; 2016 Jan; 114(1):1-6. PubMed ID: 26757421
[TBL] [Abstract][Full Text] [Related]
27. The use of cell markers in the study of human hematopoietic neoplasia.
Raskind WH; Fialkow PJ
Adv Cancer Res; 1987; 49():127-67. PubMed ID: 2890277
[No Abstract] [Full Text] [Related]
28. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis.
Shannon KM; Watterson J; Johnson P; O'Connell P; Lange B; Shah N; Steinherz P; Kan YW; Priest JR
Blood; 1992 Mar; 79(5):1311-8. PubMed ID: 1536955
[TBL] [Abstract][Full Text] [Related]
29. The Unsolved Puzzle of c-Rel in B Cell Lymphoma.
Kober-Hasslacher M; Schmidt-Supprian M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277480
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte activation and the family of NF-kappa B transcription factor complexes.
Bours V; Franzoso G; Brown K; Park S; Azarenko V; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Curr Top Microbiol Immunol; 1992; 182():411-20. PubMed ID: 1490379
[No Abstract] [Full Text] [Related]
31. Bcl-2-related genes in lymphoid neoplasia.
Wei MC
Int J Hematol; 2004 Oct; 80(3):205-9. PubMed ID: 15540893
[TBL] [Abstract][Full Text] [Related]
32. Normal structure of NFKB2, C-REL and BCL-3 gene loci in lymphoproliferative and myeloproliferative disorders.
Munzert G; Kreitmeier S; Bergmann L
Leuk Lymphoma; 2000 Jul; 38(3-4):395-400. PubMed ID: 10830747
[TBL] [Abstract][Full Text] [Related]
33. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
34. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
35. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
[TBL] [Abstract][Full Text] [Related]
36. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
